Associations of long-term cumulative C-reactive protein and glycoprotein acetyls concentrations in childhood, adolescence and adulthood with adulthood retinal microvascular structure

Oskari Repo, Markus Juonala, Harri Niinikoski, Suvi Rovio, Juha Mykkänen, Carol Y Cheung, Mika Ala-Korpela, Hanna Vaahtoranta-Lehtonen, Jaakko Nevalainen, Antti Jula, Mika Kähönen, Terho Lehtimäki, Tomi P Laitinen, Tapani Rönnemaa, Jorma Viikari, Olli Raitakari, Robyn Tapp, Katja Pahkala

    Research output: Contribution to journalArticlepeer-review

    1 Downloads (Pure)

    Abstract

    BACKGROUNG AND AIMS: Inflammation is associated with cardiovascular disease development and microvascular dysfunction. The aim of the present study is to test the hypothesis that long-term exposure to chronic inflammation in childhood and adulthood is associated with adverse retinal microvascular structure in young and mid-adulthood.

    METHODS: We analyzed data derived from the Special Turku Coronary Risk Factor Intervention Project (STRIP) and longitudinal Cardiovascular Risk in Young Finns Study (YFS). In STRIP, fundus photos were taken in young adulthood (aged 26 years), and in YFS in mid-adulthood (aged 34-49 years). Retinal microvascular measures were derived in both cohorts (arteriolar and venular diameters and tortuosity; additionally, fractal dimensions in STRIP). Cumulative exposure as the area under the curve for high-sensitivity C-reactive protein (hsCRP) and glycoprotein acetyls (GlycA), and other conventional cardiovascular risk factors was determined over a 15- and 17-year period in STRIP, and a 10-year period in YFS. Overall, retinal microvascular and cumulative hsCRP and/or GlycA were available for 344 STRIP and 1211 YFS participants, thus forming the cohort of the present study.

    RESULTS: In both cohorts, cumulative hsCRP was associated with wider venules when adjusted for sex (and age in YFS), and further for related cardiovascular risk factors. In young adulthood (STRIP), higher exposure to cumulative hsCRP was associated with decreased venular tortuosity, whereas in mid-adulthood (YFS), the association was inverse. Cumulative hsCRP was not associated with arteriolar measures whereas cumulative GlycA showed no significant association with any retinal microvascular measures.

    CONCLUSIONS: Long-term cumulative hsCRP exposure was associated with wider venules in young and mid-adulthood, whereas the associations with venular tortuosity were inconsistent. Wider retinal venules might act as a marker for cumulative inflammatory burden.

    Original languageEnglish
    Article number120595
    Number of pages9
    JournalAtherosclerosis
    Volume412
    Early online date20 Nov 2025
    DOIs
    Publication statusPublished - Jan 2026

    Bibliographical note

    © 2025 The Authors. Published by Elsevier B.V
    This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)

    Funding

    The STRIP study has been supported by the Academy of Finland (grants 206374, 294834, 251360, 275595, 307996 and 322112), the Juho Vainio Foundation, the Finnish Foundation for Cardiovascular Research, the Finnish Ministry of Education and Culture, the Finnish Cultural Foundation, the Sigrid Jusélius Foundation, Special Governmental grants for Health Sciences Research (Turku University Hospital), the Yrjö Jahnsson Foundation, the Finnish Medical Foundation, and the Turku University Foundation. The YFS has been financially supported by the Academy of Finland: grants 356,405, 322,098, 286,284, 134,309 (Eye), 126,925, 121,584, 124,282, 129,378 (Salve), 117,797 (Gendi), and 141,071 (Skidi); the Social Insurance Institution of Finland; Competitive State Research Financing of the Expert Responsibility area of Kuopio, Tampere and Turku University Hospitals (grant X51001); Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation; The Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjö Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Diabetes Research Foundation of Finnish Diabetes Association; EU Horizon 2020 (grant 755320 for TAXINOMISIS and grant 848,146 for To Aition); European Research Council (grant 742927 for MULTIEPIGEN project); Tampere University Hospital Supporting Foundation; Finnish Society of Clinical Chemistry; the Cancer Foundation Finland; pBETTER4U_EU (Preventing obesity through Biologically and bEhaviorally Tailored inTERventions for you; project number: 101080117); CVDLink (EU grant nro. 101137278) and the Jane and Aatos Erkko Foundation. K.P. is supported by Academy of Finland research fellowship (322,112). M.A.-K. was supported by a research grant from the Sigrid Jusélius Foundation, the Finnish Foundation for Cardiovascular Research, and the Research Council of Finland (grant no. 357183). The YFS has been financially supported by the Academy of Finland : grants 356,405, 322,098, 286,284, 134,309 (Eye), 126,925, 121,584, 124,282, 129,378 (Salve), 117,797 (Gendi), and 141,071 (Skidi); the Social Insurance Institution of Finland; Competitive State Research Financing of the Expert Responsibility area of Kuopio, Tampere and Turku University Hospitals (grant X51001); Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation; The Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjö Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Diabetes Research Foundation of Finnish Diabetes Association ; EU Horizon 2020 (grant 755320 for TAXINOMISIS and grant 848,146 for To Aition); European Research Council (grant 742927 for MULTIEPIGEN project); Tampere University Hospital Supporting Foundation; Finnish Society of Clinical Chemistry; the Cancer Foundation Finland; pBETTER4U_EU (Preventing obesity through Biologically and bEhaviorally Tailored inTERventions for you; project number: 101080117); CVDLink (EU grant nro. 101137278) and the Jane and Aatos Erkko Foundation . K.P. is supported by Academy of Finland research fellowship (322,112). M.A.-K. was supported by a research grant from the Sigrid Jusélius Foundation , the Finnish Foundation for Cardiovascular Research , and the Research Council of Finland (grant no. 357183). The STRIP study has been supported by the Academy of Finland (grants 206374 , 294834 , 251360 , 275595 , 307996 and 322112 ), the Juho Vainio Foundation , the Finnish Foundation for Cardiovascular Research , the Finnish Ministry of Education and Culture , the Finnish Cultural Foundation , the Sigrid Jusélius Foundation, Special Governmental grants for Health Sciences Research (Turku University Hospital) , the Yrjö Jahnsson Foundation, the Finnish Medical Foundation , and the Turku University Foundation .

    FundersFunder number
    Tampereen Tuberkuloosisäätiö
    Signe and Ane Gyllenberg Foundation
    Paavo Nurmen Säätiö
    Paavo Nurmi Foundation
    Jane ja Aatos Erkon Säätiö
    Turku University Foundation
    Signe ja Ane Gyllenbergin Säätiö
    Suomen Kulttuurirahasto
    Sigrid Juselius Foundation
    Turku University Hospital
    Research Council of Finland294834, 286,284, 124,282, 134,309, 206374, 117,797, 251360, 322,098, 275595, 126,925, 141,071, 307996, 357183, 322,112, 356,405, 121,584
    Tampereen Tuberkuloosisäätiö
    Cancer Foundation Finland
    Suomen kliinisen kemian yhdistys
    Juho Vainion Säätiö
    Emil Aaltosen Säätiö
    Suomen kliinisen kemian yhdistys
    Tampere University Hospital Supporting Foundation
    Diabetes Research Foundation
    Diabetestutkimussäätiö
    Cancer Foundation Finland
    Sydäntutkimussäätiö
    Finnish Medical Foundation
    Opetus- ja Kulttuuriministeriö
    Horizon Europe
    European Research Council742927
    Yrjö Jahnssonin Säätiö
    Sigrid Juselius Foundation
    Emil Aaltonen Foundation
    Horizon Europe848,146, 755320
    Turku University HospitalsX51001

      Fingerprint

      Dive into the research topics of 'Associations of long-term cumulative C-reactive protein and glycoprotein acetyls concentrations in childhood, adolescence and adulthood with adulthood retinal microvascular structure'. Together they form a unique fingerprint.

      Cite this